Fonidel
- Fonidel, a Factor Xa inhibitor, is utilized for preventing deep vein thrombosis (DVT) in various surgical procedures and treating acute DVT or pulmonary embolism (PE) in conjunction with warfarin.
- Selectively targeting Factor Xa, it disrupts the blood coagulation cascade, inhibiting thrombus formation without affecting platelet function.
- Dosage varies based on the indication, with close monitoring essential for patients at heightened bleeding risk.
- Contraindications include severe renal impairment, active major bleeding, and certain hypersensitivity reactions, ensuring safe and effective management of thrombotic disorders.
- Fonidel is a critical therapeutic option in anticoagulant therapy, offering precise control and management of thrombotic conditions.